Trump administration launches TrumpRx, a new online initiative Designed to lower prescription drug costs by allowing patients to purchase select drugs directly from drug manufacturers at discounted cash prices.
TrumpRx is not an online pharmacy and does not dispense prescriptions itself. Instead, it operates as a pricing and recommendation platform, listing discounted cash prices and redirecting users to participating drugmaker websites to complete purchases.
“This is a portal where people can check to see if they can find cheaper direct-to-consumer prices from drug manufacturers,” Kaye Pestaina, vice president and director of patient and consumer protection programs at KFF, told CBS News. “This is not a storefront.”
Anyone with a valid prescription can use TrumpRx, but the program is currently only available to customers who pay cash.
TrumpRx listed 43 prescription drugs at launch, covering the following conditions: diabetesweight loss, fertility treatments, cardiovascular disease, autoimmune disease, women’s health, respiratory care and smoking cessation.
Full list of available medications
Currently the following drugs are included:
ABRILADA®
Airsupra®
Azulfidine®
Azulfidine® tablet
Bevespie®
Sertreotide®
Chantix®
Cleocin®
Colesti®
Cortef®
Cytomel®
Diflucan®
Duwei®
Estrin®
Ukrisa®
Fajiga®
Genotropin®
GONAL-F®
insulin lispro
Levoxyl®
Lopid®
METRO®
Keep Moving®
Nicot®
Ovidre®
Ozempic® Pen
Premarin®
Premarin® Vaginal Cream
Prempro®
Pristique®
Protonix®
Tikosyn®
Toviaz®
WEFIND®
VeraSept®
Wegovy® Pen
Wegovy® Pills
Tofacitinib®
Xigduo® XR
Zalontin®
Zazpreet®
Zepbound®
Zyvox®
Additional drugs are expected to be added over time TrumRx website.
What to do next?
The plan comes as health care affordability remains a major concern for Americans. Prescription drug costs remain one of the top financial concerns for households across the United States, according to polls cited by CBS News.
Also read: What changes will occur to U.S. health policy in 2026?
So far, more than a dozen pharmaceutical companies, including Pfizer, Merck, AstraZeneca, Eli Lilly and Genentech, have agreed to participate, according to the White House. Officials said the program could be expanded if more manufacturers join.
President Trump also called on Congress to pass legislation that would allow TrumpRx purchases to be covered by insurance plans.
